journal
https://read.qxmd.com/read/32595771/the-severity-of-growth-hormone-deficiency-does-not-predict-the-presence-or-absence-of-brain-magnetic-resonance-imaging-abnormalities-a-retrospective-review
#21
JOURNAL ARTICLE
Patria Alba, Sarah Tsai, Naim Mitre
BACKGROUND: The Growth Hormone Research Society recommends that all patients diagnosed with growth hormone deficiency (GHD) should undergo brain magnetic resonance imaging (MRI). This is still a point of controversy in patients with mild GHD, as the level of peak growth-hormone (GH) as a predictor of brain MRI abnormality has not yet been established. The objective of this study was to determine if peak GH level, determined by stimulation tests, can predict the presence or absence of brain MRI abnormality...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595770/efficacy-and-safety-evaluation-of-human-growth-hormone-therapy-in-patients-with-idiopathic-short-stature-in-korea-a-randomised-controlled-trial
#22
JOURNAL ARTICLE
Min Ho Jung, Byung-Kyu Suh, Cheol Woo Ko, Kee-Hyoung Lee, Dong-Kyu Jin, Han-Wook Yoo, Jin Soon Hwang, Woo Yeong Chung, Heon-Seok Han, Vinay Prusty, Ho-Seong Kim
BACKGROUND: This trial evaluated the efficacy and safety of growth hormone (GH) therapy (Norditropin®; Novo Nordisk, Bagsværd, Denmark) in paediatric patients with idiopathic short stature (ISS) in Korea. METHODS: This was an open-label, parallel-group, multicentre, interventional trial (ClinicalTrials.gov identifier: NCT01778023). Pre-pubertal patients (mean age 6.2 years; height, 107.1 cm) were randomised 2:1 to 12 months' GH treatment (0.469 mg/kg/week; group A, n=36) or 6 months untreated followed by 6 months' GH treatment (group B, n=18)...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595769/the-association-between-salivary-ghrelin-levels-with-anthropometric-measures-in-underweight-normal-overweight-and-obese-healthy-adult-males
#23
JOURNAL ARTICLE
Mona Mohamed Ibrahim Abdalla, Soon Siew Choo
OBJECTIVES: The study aimed to measure salivary ghrelin levels in healthy adult males and investigate their association with age, weight, height, total as well as regional body fat and muscle mass. The study also aimed to investigate the relative contribution of body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) in predicting salivary ghrelin levels in the studied groups. METHODS: A sample of young adult males was divided into underweight, normal weight, overweight, and obese groups, according to their BMI...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595768/insulin-injection-practice-and-injection-complications-results-from-the-bangladesh-insulin-injection-technique-survey
#24
JOURNAL ARTICLE
Abm Kamrul-Hasan, Ajit Kumar Paul, Mohammad Nurul Amin, Md Abu Jar Gaffar, Md Asaduzzaman, Mohammad Saifuddin, Marufa Mustari, Md Jahangir Alam, Mohammad Moin Shahid, K M Nahid-Ul-Haque, Muhammad Shah Alam, Md Motiur Rahman, Samir Kumar Talukder, Md Abdul Kader, Farhana Akter, Mohammad Abdul Hannan, Palash Kumar Chanda, Muhammed Abu Bakar, Shahjada Selim
INTRODUCTION: Diabetes mellitus is highly prevalent in Bangladesh and insulin is often needed for diabetes control. We lack sufficient data on the insulin injection technique and injection-related complications. METHODS: The Bangladesh Insulin Injection Technique Survey (BIITS) was conducted in 2018 in 18 centres throughout Bangladesh, involving 847 patients taking insulin for at least 6 months. All of the study subjects were interviewed using a structured questionnaire focusing on key insulin injection parameters...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595767/anticancer-drug-induced-thyroid-dysfunction
#25
REVIEW
Saptarshi Bhattacharya, Alpesh Goyal, Parjeet Kaur, Randeep Singh, Sanjay Kalra
Cancer immunotherapy and targeted therapy, though less toxic than conventional chemotherapy, can increase the risk of thyroid dysfunction. Immune checkpoint inhibitors render the cancer cells susceptible to immune destruction, but also predispose to autoimmune disorders like primary hypothyroidism as well as central hypothyroidism secondary to hypophysitis. Tyrosine kinase inhibitors act by blocking vascular endothelial growth factor receptors and their downstream targets. Disruption of the vascular supply from the inhibition of endothelial proliferation damages not only cancer cells but also organs with high vascularity like the thyroid...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595766/the-interplay-between-pituitary-health-and-diabetes-mellitus-the-need-for-hypophyseo-vigilance
#26
REVIEW
Saptarshi Bhattacharya, Sanjay Kalra, Deep Dutta, Deepak Khandelwal, Rajiv Singla
The anterior and posterior hypophyseal hormones alter glucose metabolism in health and disease. Secondary diabetes may occur due to hypersecretion of anterior pituitary hormones like adrenocorticotrophic hormone in Cushing's disease and growth hormone in acromegaly. Other hormones like prolactin, gonadotropins, oxytocin and vasopressin, though not overtly associated with causation of diabetes, have important physiological role in maintaining glucose homeostasis. Hypoglycaemia is not an unusual occurrence in hypopituitarism...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595765/pragmatic-opioid-use-in-painful-diabetic-neuropathy
#27
REVIEW
Yatan Pal Singh Balhara, Shalini Singh, Sanjay Kalra
The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595764/diabetic-polyneuropathy-advances-in-diagnosis-and-intervention-strategies
#28
REVIEW
Solomon Tesfaye, Gordon Sloan
Over half of people with diabetes mellitus develop diabetic polyneuropathy (DPN), which is a major cause of reduced quality of life due to disabling neuropathic pain, sensory loss, gait instability, fall-related injury, and foot ulceration and amputation. The latter represents a major health and economic burden, with lower limb amputation rates related to diabetes increasing in the UK. There is a need for early diagnosis of DPN so that early management strategies may be instigated, such as achieving tight glucose control and management of cardiovascular risk factors, in an attempt to slow its progression...
April 2020: European Endocrinology
https://read.qxmd.com/read/32595763/person-centred-obesity-care-techniques-thresholds-tools-and-targets
#29
EDITORIAL
Sanjay Kalra, Nitin Kapoor, Sunil Kota, Sambit Das
Obesity is a complex syndrome with multifactorial etiopathogenesis, multifaceted clinical presentations, multidimensional therapeutic approaches, and multipronged treatment strategies. These create the need for a person-centred approach to the management of obesity. This opinion piece explores the spectrum of person-centred obesity care. The authors describe the person-centred nature of techniques used to detect obesity, the thresholds used to diagnose it, the tools (treatment strategies) used to manage it, and the therapeutic outcomes aimed for...
April 2020: European Endocrinology
https://read.qxmd.com/read/31616503/comparative-efficacy-and-safety-among-sodium-glucose-cotransporter-2-inhibitors-in-type-2-diabetes-results-from-a-retrospective-single-centre-study
#30
JOURNAL ARTICLE
Manash P Baruah, Sanjay Kalra
Introduction: This retrospective analysis compared the real-world effectiveness and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus in India. Methods: All patients initiated on canagliflozin (C; 100 mg), dapagliflozin (D; 10 mg) and empagliflozin (E; 10 mg) between January and December 2016 were identified from an urban outpatient facility. Intra- and inter-group changes in glycaemic and metabolic parameters were recorded. Results: At week 48 (median follow-up), mean changes from baseline in the C (n=29), D (n=65) and E groups (n=27), respectively, were -1...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616502/co-existing-non-communicable-diseases-and-mental-illnesses-amongst-the-elderly-in-punjab-india
#31
JOURNAL ARTICLE
Madhur Verma, Sandeep Grover, Jaya Prasad Tripathy, Tarundeep Singh, Sharath Burugina Nagaraja, Soundappan Kathirvel, Gopal Singh, Ritu Nehra
Background: There is scant literature from India assessing the burden of mental disorders among elderly patients with non-communicable diseases (NCDs). This study aimed to determine the prevalence of depression and generalised anxiety disorder (GAD) among the elderly population with diabetes and/or hypertension and risk factors for psychiatric morbidity. Methodology: A cross-sectional study was conducted between September-December 2017 by using a semi-structured questionnaire amongst an elderly population (n=320), who were attending an NCD clinic in a rural district in the northern state of Punjab, India...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616501/performance-of-variables-in-screening-for-gestational-diabetes
#32
JOURNAL ARTICLE
Laura Hautala, Erling Englund, Sahruh Turkmen
Introduction: Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. The strategies used to screen for GDM vary both internationally and nationally. Therefore, we investigated the performance of the capillary random plasma glucose (RPG) test, maternal body mass index (BMI) and maternal age in predicting GDM. Methods: In a retrospective cohort study, we included pregnant women without pre-existing diabetes or metabolic disease who gave birth in Västernorrland County, Sweden, in 2015-2016...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616500/clinical-presentation-and-outcomes-of-phaeochromocytomas-paragangliomas-in-neurofibromatosis-type-1
#33
JOURNAL ARTICLE
Ahmed Al-Sharefi, Usman Javaid, Petros Perros, John Ealing, Peter Truran, Sath Nag, Shafie Kamaruddin, Kamal Abouglila, Fiona Cains, Lauren Lewis, Robert Andrew James
Introduction: Patients with neurofibromatosis type 1 (NF1) are at risk of developing phaeochromocytomas/paragangliomas (PHAEO/PG). Unlike in other familial PHAEO/PG syndromes, there are no published guidelines regarding screening in asymptomatic or normotensive patients with NF1. This strategy may be associated with preventable morbidities in those patients who ultimately present with symptomatic PHAEO/PG. Objective: To describe the mode of presentation and the incidence of adverse clinical outcomes attributed to PHAEO/PG in NF1...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616499/metastatic-men1-syndrome-treated-with-lutetium-177-a-case-report
#34
Emre Gezer, Berrin Çetinarslan, Zeynep Cantürk, İIlhan Tarkun, Mehmet Sözen, Alev Selek
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant endocrine tumour syndrome characterised by three main manifestations: primary hyperparathyroidism (78-94%), gastroenteropancreatic neuroendocrine tumours (GEP-NETs) (35-78%) and pituitary adenomas (20-65%). For metastatic and inoperable GEP-NETs, there are some interventional and medical therapies. Peptide receptor radionuclide therapy (PRRT) with Yttrium-90 (90 Y) and Lutetium-177 (177 Lu) is one of the important radiotherapies. Herein we describe a case of MEN1 syndrome with inoperable metastatic GEP-NETs who had excellent response to the treatment with six cycles of 177 Lu-DOTATATE...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616498/male-obesity-related-secondary-hypogonadism-pathophysiology-clinical-implications-and-management
#35
REVIEW
Cornelius J Fernandez, Elias C Chacko, Joseph M Pappachan
The single most significant risk factor for testosterone deficiency in men is obesity. The pathophysiological mechanisms involved in male obesity-related secondary hypogonadism are highly complex. Obesity-induced increase in levels of leptin, insulin, proinflammatory cytokines and oestrogen can cause a functional hypogonadotrophic hypogonadism with the defect present at the level of the hypothalamic gonadotrophin-releasing hormone (GnRH) neurons. The resulting hypogonadism by itself can worsen obesity, creating a self-perpetuating cycle...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616497/palaeolithic-diet-in-diabesity-and-endocrinopathies-a-vegan-s-perspective
#36
REVIEW
Lovely Gupta, Deepak Khandelwal, Priti Rishi Lal, Sanjay Kalra, Deep Dutta
INTRODUCTION: The Palaeolithic diet is designed to resemble that of human hunter-gatherer ancestors thousands to millions of years ago. This review summarises the evidence and clinical application of this diet in various disorders. An empiric vegan variant of it has been provided, keeping in mind vegan food habits. REVIEW OF THE LITERATURE: different types of Palaeolithic diets in vogue include the 80/20, the autoimmune, the lacto, the Palaeolithic vegan and the Palaeolithic ketogenic...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616496/advances-in-type-1-diabetes-technology-over-the-last-decade
#37
REVIEW
Chelsea Zimmerman, Anastasia Albanese-O'Neill, Michael J Haller
The past 10 years have witnessed rapid advances in the technology used to treat patients with type 1 diabetes (T1D). While the disease burden is still high, these advances have contributed to improvements in both glycaemic control and quality of life for many of those affected. New technologies allow for individualisation of care, as patients are able to work with their providers to determine which systems best fit their lifestyle and needs. In addition, thanks to improved glucose monitoring technologies, patients can now simultaneously improve glycaemic control and reduce hypoglycaemia, thereby mitigating risk for acute and chronic complications...
August 2019: European Endocrinology
https://read.qxmd.com/read/31616495/defining-disease-progression-and-drug-durability-in-type-2-diabetes-mellitus
#38
EDITORIAL
Sanjay Kalra, Nor Azmi Kamaruddin, Jayanti Visvanathan, Ravi Santani
This communication shares insights into the definition of disease progression and drug durability in type 2 diabetes. Disease progression may be defined as gradual worsening of beta-cell function, clinically observed as an increase in drug dosage, drug frequency or number of glucose lowering drugs needed to maintain HbA1c control; and/or a ≥0.5% rise in HbA1c, unexplained by acute, modifiable factors, while using the same drug regimen; and/or as the occurrence or worsening of cardiovascular or microvascular complications, in spite of standard care, over a pre-specified time period...
August 2019: European Endocrinology
https://read.qxmd.com/read/31244911/the-glucocoper-an-exploratory-study-to-assess-coping-mechanisms-of-women-diagnosed-with-diabetes-mellitus
#39
JOURNAL ARTICLE
Bharti Kalra, Sanjay Kalra, Yatan Pal Singh Balhara, Komal Verma, Aas Azam, Fouzia A Shaikh
Diabetes distress can be managed effectively by coping-skill training. To improve coping skills, one must begin by analysing current coping styles of an individual. The GlucoCoper has been developed as a brief, simple, easy-to-administer tool for assessing the coping mechanism of people with diabetes mellitus. The GlucoCoper includes six items rated on a graphic visual analogue scale. These include four items to assess positive coping skills (acceptance, optimism, planning and action) and two items to assess negative coping mechanisms (negativity and blame)...
April 2019: European Endocrinology
https://read.qxmd.com/read/31244910/primary-leiomyosarcoma-of-the-thyroid-gland-a-rare-malignancy
#40
Bhasker Reddy, Vivek Aggarwal, Ajay Kumar Ajmani, Seema Sachan, Deepak Khandelwal
Primary leiomyosarcoma (LMS) of thyroid is rare malignant neoplasm usually seen in elderly patients. These tumours are characterised by a rapidly growing mass in the neck, difficult to diagnose preoperatively and are highly aggressive with high recurrence rates in spite of radical surgery, chemotherapy and radiotherapy. We herein report a case of 50-year-old female with a rapidly growing painless mass in the neck. Total thyroidectomy with bilateral neck node clearance was done. Histology and Immunohistochemistry revealed primary LMS of thyroid gland...
April 2019: European Endocrinology
journal
journal
55674
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.